EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients

Enrica Borsi iD, Ilaria Vigliotta iD, Andrea Poletti iD, Gaia Mazzocchetti iD, Vincenza Solli iD, Luca Zazzeroni, Marina Martello iD, Silvia Armuzzi iD, Barbara Taurisano, Ajsi Kanapari, Ignazia Pistis, Elena Zamagni iD und 10 weitere

Cells · 2024

DOI: 10.3390/cells13080657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Enrica Borsi und 21 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Single-Cell Analysis, Mutation, Clonal Hematopoiesis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Ministero della Salute, Associazione Italiana Leucemia, Linfomi e Mieloma-AIL ODV, Bologna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis of indeterminate potential (CHIP) refers to the phenomenon where a hematopoietic stem cell acquires fitness-increasing mutation(s), resulting in its clonal expansion. CHIP is frequently observed in multiple myeloma (MM) patients, and it is associated with a worse outcome. High-throughput amplicon-based single-cell DNA sequencing was performed on circulating CD34+ cells collected from twelve MM patients before autologous stem cell transplantation (ASCT). Moreover, in four MM patients, longitudinal samples either before or post-ASCT were collected. Single-cell sequencing and data analysis were assessed using the MissionBio Tapestri® platform, with a targeted panel of 20 leukemia-associated genes. We detected CHIP pathogenic mutations in 6/12 patients (50%) at the time of transplant. The most frequently mutated genes were TET2, EZH2, KIT, DNMT3A, and ASXL1. In two patients, we observed co-occurring mutations involving an epigenetic modifier (i.e., DNMT3A) and/or a gene involved in splicing machinery (i.e., SF3B1) and/or a tyrosine kinase receptor (i.e., KIT) in the same clone. Longitudinal analysis of paired samples revealed a positive selection of mutant high-fitness clones over time, regardless of their affinity with a major or minor sub-clone. Copy number analysis of the panel of all genes did not show any numerical alterations present in stem cell compartment. Moreover, we observed a tendency of CHIP-positive patients to achieve a suboptimal response to therapy compared to those without. A sub-clone dynamic of high-fitness mutations over time was confirmed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaSingle-Cell AnalysisMutationClonal HematopoiesisHumansMaleMiddle AgedFemaleAgedHematopoietic Stem Cell TransplantationSequence Analysis, DNAAdultClonal Evolution

Stichwörter der Autor:innen

clonal hematopoiesis of indeterminate potential (CHIP)multiple myelomasingle-cell DNA sequencingstem cells

Autor:innen und Institutionen

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", 40138 Bologna, Italy.
  • Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.

ORCID-Profile: Enrica Borsi, Ilaria Vigliotta, Andrea Poletti, Gaia Mazzocchetti, Vincenza Solli, Marina Martello, Silvia Armuzzi, Elena Zamagni, Katia Mancuso, Ilaria Rizzello, Elisa Dan, Barbara Sinigaglia

Förderung

  • Italian Association for Cancer Research
  • Ministero della Salute
  • Associazione Italiana Leucemia, Linfomi e Mieloma-AIL ODV, Bologna
  • AIRC—Associazione Italiana Ricerca sul Cancro
  • Associazione Italiana Leucemia, Linfomi e Mieloma—AIL ODV, Bologna

Zitieren

APA

Borsi, E., Vigliotta, I., Poletti, A., Mazzocchetti, G., Solli, V., Zazzeroni, L., Martello, M., Armuzzi, S., Taurisano, B., Kanapari, A., Pistis, I., Zamagni, E., Pantani, L., Rocchi, S., Mancuso, K., Tacchetti, P., Rizzello, I., Rizzi, S., Dan, E., …, & Terragna, C. (2024). Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients. Cells. https://doi.org/10.3390/cells13080657

Vancouver

Borsi E, Vigliotta I, Poletti A, Mazzocchetti G, Solli V, Zazzeroni L, et al. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients. Cells. 2024. doi:10.3390/cells13080657

BibTeX
@article{Borsi2024,
  author = {Borsi, Enrica and Vigliotta, Ilaria and Poletti, Andrea and Mazzocchetti, Gaia and Solli, Vincenza and Zazzeroni, Luca and Martello, Marina and Armuzzi, Silvia and Taurisano, Barbara and Kanapari, Ajsi and Pistis, Ignazia and Zamagni, Elena and Pantani, Lucia and Rocchi, Serena and Mancuso, Katia and Tacchetti, Paola and Rizzello, Ilaria and Rizzi, Simonetta and Dan, Elisa and Sinigaglia, Barbara and Cavo, Michele and Terragna, Carolina},
  title = {Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13080657}
}
Kostenlos starten →